OSE Immunotherapeutics SA (EPA:OSE)
5.02
+0.01 (0.30%)
At close: Dec 5, 2025
OSE Immunotherapeutics Employees
OSE Immunotherapeutics had 64 employees as of December 31, 2024. The number of employees increased by 9 or 16.36% compared to the previous year.
Employees
64
Change (1Y)
9
Growth (1Y)
16.36%
Revenue / Employee
€1,303,672
Profits / Employee
€585,078
Market Cap
112.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
OSE Immunotherapeutics News
- 2 months ago - OSE Immunotherapeutics (ORPOF) Appoints Interim CEO Marc Le Bozec - GuruFocus
- 2 months ago - OSE Immunotherapeutics replaces CEO Nicolas Poirier, appoints Marc Le Bozec as interim CEO - Seeking Alpha
- 2 months ago - OSE Immunotherapeutics SA (ORPOF) Shareholder/Analyst Call Transcript - Seeking Alpha